ConductScience.org, home

Gene · 81502

HM13: histocompatibility minor 13

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. HM13: histocompatibility minor 13. Genes, record 81502. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/81502

On this page

Gene

Symbol
HM13
HGNC
Name
histocompatibility minor 13
HGNC
NCBI Gene ID
81502
NCBI Gene
HGNC ID
HGNC:16435
HGNC
Ensembl
ENSG00000101294
NCBI Gene
Aliases
H13, HM13-IT1, IMP1, IMPAS, IMPAS-1, MSTP086, PSENL3, PSL3, SPP, SPPL1, dJ324O17.1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q8TCT9Signal peptide peptidase3770Ensembl, GeneID, HGNC

Source UniProt

Patents30

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1449150Q8TCT9Espacenet
EP 4650780 A22025-11-196781Q8TCT9Espacenet
EP 4641201 A22025-10-296568Q8TCT9Espacenet
JP 2025529142 A2025-09-041974Q8TCT9Espacenet
US 12371689 B22025-07-291974Q8TCT9Espacenet
JP 2025517969 A2025-06-126568Q8TCT9Espacenet
JP 2025517970 A2025-06-126781Q8TCT9Espacenet
US 11446398 B22022-09-2038438Q8TCT9Espacenet
US 11400116 B22022-08-025174Q8TCT9Espacenet
JP 2022524081 A2022-04-27141409Q8TCT9Espacenet

1 to 10 of 30

See all 30 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants800

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleHM13 papersNewest fiscal year
P30CA008748Cancer Center Support Grant62025
P30CA016672Cancer Center Support Grant42025
P30DK040561Boston Area Nutrition Obesity Research Center (NORC)42025
P30ES005605Environmental Health Sciences Research Center42025
P01AI120943Molecular Mechanisms of Filoviral-host Interactions32025
P30CA046934University of Colorado Cancer Center Support Grant32025
K24HL137013Mentoring Research in Precision Medicine for Lung Disease22025
K24HL138188Defining Pathways in COPD Patient Oriented Research22025
P01CA097132Sphingolipids in Cancer Biology and Therapy22025
P30CA016042Cancer Center Support Grant22025

1 to 10 of 800Source NIH's project files

See all 800 nih grants

Papers1,735

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Investigation of statistical properties of electromagnetic beams modulated by surface plasmon polaritons.Opt Lett202642771393PubTator, text miningPubMed
Chinese EFL learners' self-perceived pronunciation accuracy: a structural equation modeling study of L2 selves, foreign language anxiety, and speaking self-efficacy.BMC Psychol202642351294PubTator, text miningPubMed
Dimeric architecture and membrane thinning govern substrate recognition by human signal peptide peptidase.Res Sq202642281969PubTator, text miningPubMed
Investigating the Effects of a Novel Salmon-Derived Protein Peptide on Markers of Recovery From Exercise-Induced Muscle Damage.Int J Sport Nutr Exerc Metab202642248424PubTator, text miningPubMed
Integrated single-cell and bulk RNA-seq analysis reveals an NK-cell-related immune landscape and a prognostic signature for hepatocellular carcinoma.Discov Oncol202642177711PubTator, text miningPubMed
Hepatitis C virus p7 regulates Core protein processing via signal peptide peptidase to promote virion assembly.J Virol202641995348PubTator, text miningPubMed
Mechanistic insights and therapeutic potential of sphingosine‑1‑phosphate in the development of pulmonary fibrosis (Review).Mol Med Rep202641860030PubTator, text miningPubMed
Plasmons Enable Ultralow Threshold Solid-State Triplet Fusion Upconversion with a 2D Sensitizer.Nano Lett202641838853PubTator, text miningPubMed
Generation and characterization of human induced pluripotent stem cells from neuropathologically confirmed multiple system atrophy patient-derived fibroblasts.Front Immunol202641808829PubTator, text miningPubMed
Identification of isoform switching events linked with esophageal adenocarcinoma patient survival informs novel prognostic and therapeutic targets.Cell Death Dis202641807370PubTator, text miningPubMed

1 to 10 of 1,735

See all 1,735 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/81502

GET https://conductscience.org/api/genes/v1/81502/patents?page=2